Literature DB >> 1932395

Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.

C M Mazure1, J C Nelson, P I Jatlow, M B Bowers.   

Abstract

The relationship of plasma free homovanillic acid (HVA) and methoxyhydroxyphenylglycol (MHPG) to early clinical response was prospectively studied in a new series of acutely psychotic inpatients given a fixed dose of perphenazine elixir for 10 days. Elevated pretreatment plasma HVA but not MHPG was significantly associated with good response. Change in HVA was correlated with a favorable response and a significant decline in MHPG was found in responders. Results suggest that HVA can provide a useful clinical predictor of response, and that both dopamine metabolism and noradrenergic functioning, as measured by plasma HVA and MHPG, are reduced in effective neuroleptic treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932395     DOI: 10.1016/0006-3223(91)90309-a

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  7 in total

1.  T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability.

Authors:  R Joober; C Benkelfat; K Brisebois; A Toulouse; G Turecki; S Lal; D Bloom; A Labelle; P Lalonde; D Fortin; M Alda; R Palmour; G A Rouleau
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

2.  Monoamine activity reflected in urine of young patients with obsessive compulsive disorder, psychosis with and without reality distortion and healthy subjects: an explorative analysis.

Authors:  R D Oades; B Röpcke; C Eggers
Journal:  J Neural Transm Gen Sect       Date:  1994

3.  The biochemical womb of schizophrenia: A review.

Authors:  N Gaur; S Gautam; M Gaur; P Sharma; G Dadheech; S Mishra
Journal:  Indian J Clin Biochem       Date:  2008-12-20

Review 4.  Genetics of schizophrenia: from animal models to clinical studies.

Authors:  Ridha Joober; Patricia Boksa; Chawki Benkelfat; Guy Rouleau
Journal:  J Psychiatry Neurosci       Date:  2002-09       Impact factor: 6.186

5.  Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia.

Authors:  Hikaru Hori; Reiji Yoshimura; Asuka Katsuki; Kiyokazu Atake; Ryohei Igata; Yuki Konishi; Hiroki Beppu; Hirotaka Tominaga
Journal:  Int J Mol Sci       Date:  2017-03-06       Impact factor: 5.923

6.  Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion.

Authors:  Tanja Veselinović; Ingo Vernaleken; Paul Cumming; Uwe Henning; Lina Winkler; Peter Kaleta; Michael Paulzen; Christian Luckhaus; Gerhard Gründer
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-27       Impact factor: 2.570

7.  Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function.

Authors:  Kenji Takeyoshi; Masatake Kurita; Satoshi Nishino; Mika Teranishi; Yukio Numata; Tadahiro Sato; Yoshiro Okubo
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-15       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.